drug

Cognitive remediation training (CT)

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by University of California Riverside at C.I. Trials, Inc.-Inland Empire
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
NCT00333177Phase 4Completed

KOLs & investigators

1
Keith H. Nuechterlein, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
trial
Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
PHASE4
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
KOL
Keith H. Nuechterlein, PhD
KOL score —
person